Folsäure und Neuralrohrdefekte: Ist ein Umdenken erforderlich?

Alexander Ströhle, Andreas Hahn

 

  1. Cordero AM, Crider KS, Rogers LM, Cannon MJ, Berry RJ. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: world health organization guidelines. MMWR Morb Mortal Wkly Rep. 2015; 64(15):421–3.
  2. Obeid R, Oexle K, Rißmann A, Pietrzik K, Koletzko B. Folate status and health: challenges and opportunities. J Perinat Med. 2015a Mar 31. pii: /j/jpme.ahead-of-print/jpm-2014-0346/jpm-2014-0346.xml. doi: 10.1515/jpm-2014-0346. [Epub ahead of print] PubMed PMID: 25825915.
  3. Ströhle A, Wolters M, Hahn A. Nährstoffsupplemente - Möglichkeiten und Grenzen. Teil 2: Ausgewählte Risikogruppen - Supplemente in der Schwangerschaft, Med Monatsschr Pharm. 2013; 36: 252–266
  4. Ströhle A, Wolters M, Hadji P, Hahn A. Folsäure und Neuralrohrdefekte - Ein Update, Frauenarzt. 2014a; 55: 596–605
  5. Czeizel AE, Dudás I, Paput L, Bánhidy F. Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins? Ann Nutr Metab. 2011 (4): 263–71. 
  6. Czeizel AE, Dudás I, Vereczkey A, Bánhidy F. Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients. 2013; 5(11): 4760–75. 
  7. Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Res A Clin Mol Teratol. 2009; 85(4): 260–8. 
  8. Czeizel AE. Periconceptional folic acid-containing multivitamin supplementation for the prevention of neural tube defects and cardiovascular malformations. Ann Nutr Metab. 2011; 59(1): 38–40. 
  9. Tsang BL, Devine OJ, Cordero AM, Marchetta CM, Mulinare J, Mersereau P, Guo J, Qi YP, Berry RJ, Rosenthal J, Crider KS, Hamner HC. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies. Am J Clin Nutr. 2015; pii: ajcn099994. [Epub ahead of print] PubMed PMID: 25788000.
  10. Crider KS, Devine O, Hao L, Dowling NF, Li S, Molloy AM, Li Z, Zhu J, Berry RJ. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ. 2014; 349: g4554. 
  11. Crider et al. 2015
  12. Marchetta CM, Devine OJ, Crider KS, Tsang BL, Cordero AM, Qi YP, Guo J, Berry RJ, Rosenthal J, Mulinare J, Mersereau P, Hamner HC. Assessing the association between natural food folate intake and blood folate concentrations: a systematic review and Bayesian meta-analysis of trials and observational studies. Nutrients. 2015; 7(4): 2663–86. 
  13. Duffy ME, Hoey L, Hughes CF, Strain JJ, Rankin A, Souverein OW, Dullemeijer C, Collings R, Hooper L, McNulty H. Biomarker responses to folic acid intervention in healthy adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014; 99(1):96–106. 
  14. Obeid R, Kirsch SH, Dilmann S, Klein C, Eckert R, Geisel J, Herrmann W. Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial. Eur J Nutr. 2015b; [Epub ahead of print] PubMed PMID: 25943647.
  15. Patanwala I, King MJ, Barrett DA, Rose J, Jackson R, Hudson M, Philo M, Dainty JR, Wright AJ, Finglas PM, Jones DE. Folic acid handling by the human gut: implications for food fortification and supplementation. Am J Clin Nutr. 2014; 100(2) 593–9. 
  16. Pfeiffer CM, Sternberg MR, Fazili Z, Lacher DA, Zhang M, Johnson CL, Hamner HC, Bailey RL, Rader JI, Yamini S, Berry RJ, Yetley EA. Folate status and concentrations of serum folate forms in the US population: National Health and Nutrition Examination Survey 2011-2. Br J Nutr. 2015:1–13.
  17. World Health Organization. Guideline: optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva (Switzerland): World Health Organization; 2015
  18. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects: implications for prevention. JAMA 1995;274:1698–702
  19. Clarke R, Bennett D. Folate and prevention of neural tube defects. BMJ. 2014; 349: g4810. 
  20. Ströhle A, Wolters M, Hahn A. Sicherheit von Folsäure – Fakten und Fiktionen. Med Monatsschr Pharm. 2015 (im Druck)
  21. Obeid R, Oexle K, Rißmann A, Pietrzik K, Koletzko B. Folate status and health: challenges and opportunities. J Perinat Med. 2015a. pii: /j/jpme.ahead-of-print/jpm-2014-0346/jpm-2014-0346.xml. doi: 10.1515/jpm-2014-0346. [Epub ahead of print] PubMed PMID: 25825915.
  22. Ströhle A, Wolters M, Willers J, Hadji P, Hahn A . Mikronährstoffe in verschiedenen Lebensphasen der Frau (Teil 3) Schwangerschaft: Folsäure und DHA für einen optimalen Start ins Leben, Gyne 35 2014b; 5: 33–39
  23. Deutsche Gesellschaft für Ernährung e.V. (DGE) 12. Ernährungsbericht. 2012: 40–85.
  24. Deutsche Gesellschaft für Ernährung e.V. (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE), Schweizerische Vereinigung für Ernährung (SVE): Referenzwerte für die Nährstoffzufuhr. Folat. Umschau Buchverlag, Neustadt a. d. Weinstraße 2013; Online: www.dge.de/pdf/ws/Referenzwerte-2013-Folat.pdf
  25. Wald NJ, Law MR, Morris JK et al.: Quantifying the effect of folic acid. Lancet 358, 2001; 2069–2073.
  26. Berti C, Fekete K, Dullemeijer C et al.: Folate intake and markers of folate status in women of reproductive age, pregnant and lactating women: a meta-analysis. J Nutr Metab, 2012; 470656.
  27. Obeid R, Koletzko B, Pietrzik K: Critical evaluation of lowering the recommended dietary intake of folate. Clin Nutr, 2014; pii:S0261-5614(13)00336-1. 
  28. Brämswig S, Prinz-Langenohl R, Lamers Y, Tobolski O, Wintergerst E, Berthold HK, Pietrzik K. supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women. Int J Vitam Nutr Res. 2009; 79(2):61–70. 
  29. Pietrzik K, Lamers Y, Brämswig S, Prinz-Langenohl R. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr. 2007;86(5):1414-9. 
  30. Lamers Y, Prinz-Langenohl R, Brämswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr. 2006; 84(1):156–61. 
  31. Cortese C, Motti C: MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr 4, 2001; 493–497.
  32. Yan L, Zhao L, Long Y et al.: Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. PLoS One 7 ,2012; e41689.
  33. Lacasaña M, Blanco-Muñoz J, Borja-Aburto VH et al.: Effect on risk of anencephaly of gene-nutrient interactions between methylenetetrahydrofolate reductase C677T polymorphism and maternal folate, vitamin B12 and homocysteine profile. Public Health Nutr 15 ,2012; 1419-1428.
  34. Crider KS, Zhu JH, Hao L et al.: MTHFR 677C->T genotype is associated with folate and omocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr 93 ,2011; 1365–1372.
  35. Molloy AM, Daly S, Mills JL et al.: Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349 ,1997; 1591–1593.
  36. Hertfelder 2004
  37. Rosenquist TH, Ratashak SA, Selhub J: Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93 ,1996; 15227–15232.
  38. Rosenquist TH, Schneider AM, Monogham DT: N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities. FASEB J 13 ,1999; 1523–1531.
  39. Vollset SE, Refsum H, Irgens LM et al.: Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 71 ,2000; 962–968.
  40. Ray JG, Laskin CA: Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 20 ,1999; 519–529.
  41. Mills JL, McPartlin JM, Kirke PN et al.: Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345 ,1995; 149–151.
  42. Ashfield-Watt PA, Pullin CH, Whiting JM et al.: Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 76 ,2002; 180–186.
  43. Litynski P, Loehrer F, Linder L et al.: Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C-->T polymorphism of methylenetetrahydrofolate reductase. Eur J Clin Invest 32 ,2002; 662–668.
  44. Fohr IP, Prinz-Langenohl R, Brönstrup A et al.: 5,10-methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 75 ,2002; 275–282.
  45. Bailey SW, Ayling JE: The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA. 2009; 106:15424–15429.
  46. Lucock 2004
  47. Kelly P, McPartlin J, Goggins M et al.: Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr. 1997; 65: 1790–1795.
  48. Sweeney MR, McPartlin J, Scott J. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health. 2007; 7: 41. 
  49. Kalmbach RD, Choumenkovitch SF, Troen AM et al.: Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr. 2008; 88: 763–768.
  50. Wright AJ, Dainty JR, Finglas PM: Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr. 2007; 98:667–675.
  51. Obeid R, Herrmann W: The emerging role of unmetabolized folic acid in human diseases: myth or reality? Curr Drug Metab. 2012; 13: 1184–1195.
  52. Stover PJ, MacFarlane AJ, Field MS. Bringing clarity to the role of MTHFR variants in neural tube defect prevention. Am J Clin Nutr. 2015. pii: ajcn111088. [Epub ahead of print] PubMed PMID: 25971720.
  53. Troen AM, Mitchell B, Sorensen B et al.: Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006; 136:189–194. 
  54. Hirsch 2011
  55. Haberg SE, London SJ, Stigum H, Nafstad P et al. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child 2009; 94: 180–84.
  56. Kiefte-de Jong JC, Timmermans S, Jaddoe VW, Hofman A et al. High circulating folate and vitamin B-12 concentrations in women during pregnancy are associated with increased prevalence of atopic dermatitis in their offspring. J Nutr. 2012;142:731–8. 
  57. Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Eff ect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol. 2009; 170: 1486–93.
  58. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012; 3: 21–38. 
  59. Brown SB, Reeves KW, Bertone-Johnson ER. Maternal folate exposure in pregnancy and childhood asthma and allergy: a systematic review. Nutr Rev. 2014; 72: 55–64. 
  60. Han 2013
  61. Crider KS, Cordero AM, Qi YP, Mulinare J et al. Prenatal folic acid and risk of asthma in children: a systematic review and meta-analysis. Am J Clin Nutr. 2013; 98:1272–81. 
  62. Leeming RJ, Lucock M. Autism: Is there a folate connection? J Inherit Metab Dis. 2009; 32: 400–2. 
  63. Rogers EJ. Has enhanced folate status during pregnancy altered natural selection and possibly Autism prevalence? A closer look at a possible link. Med Hypotheses. 2008; 71:406–10. 
  64. Roth C, Magnus P, Schjølberg S, Stoltenberg C et al. Folic acid supplements in pregnancy and severe language delay in children. JAMA. 2011; 306: 1566–73. 
  65. Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr. 2012; 96: 80–9.
  66. Surén P, Roth C, Bresnahan M, Haugen M et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013; 309: 570–7.
  67. Veena SR, Krishnaveni GV, Srinivasan K, Wills AK et al. Higher maternal plasma folate but not vitamin B-12 concentrations during pregnancy are associated with better cognitive function scores in 9- to 10- year-old children in South India. J Nutr. 2010; 140: 1014–22.
  68. Berry RJ, Crider KS, Yeargin-Allsopp M. Periconceptional folic acid and risk of autism spectrum disorders. JAMA. 2013; 309: 611–3.
  69. Obeid R, Kasoha M, Kirsch SH et al.: Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood. Am J Clin Nutr. 2010; 92: 1416–1422. 
  70. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can. 2006; 8: 680–9.
  71. Picciano MF, McGuire MK. Use of dietary supplements by pregnant and lactating women in North America. Am J Clin Nutr. 2009; 2: 663S–7S. 
  72. Kaiser L, Allen LH; American Dietetic Association. Position of the American Dietetic Association: nutrition and lifestyle for a healthy pregnancy outcome. J Am Diet Assoc. 2008;108(3):553–61. 
  73. Ströhle A. [Folic acid and neural tube defects: dose-response relationship confirmed]. Med Monatsschr Pharm. 2014; 37(11): 419–20. 
  74. Ströhle 2005
  75. Han YY, Blatter J, Brehm JM, Forno E, Litonjua AA, Celedón JC. Diet and asthma: vitamins and methyl donors. Lancet Respir Med. 2013 Dec;1(10):813-22.
  76. Hertfelder H-J, Gnida C, Pötzsch B et al.: MTHFR-Polymorphismus C677T. Sinn und Unsinn der Diagnostik. Dtsch Ärztebl 101 (2004) 3100-3101.
  77. Hirsch S, Miranda D, Muñoz E et al.: Natural killer cell cytotoxicity is not regulated by folic acid Haberg SE, London SJ, Nafstad P, et al. Maternal folate levels in pregnancy and asthma in children at age 3 years. J Allergy Clin Immunol 2011;127: 262-64, 4 e1.
  78. Lucock M: Is folic acid the ultimate functional food component for disease prevention? BMJ. 2004; 328:211-214.
  79. Ströhle A, Wolters M, Hahn A. Folic acid and colorectal cancer prevention: molecular mechanisms and epidemiological evidence (Review). Int J Oncol. 2005 (6):1449–64.